BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10488761)

  • 1. A macrophage fusion assay for rapid screening of cloned HIV-1 Env using dual recombinant vaccinia viruses expressing distinct RNA polymerases.
    Isaacs SN; Yi Y; Singh A; Collman RG
    J Virol Methods; 1999 Aug; 81(1-2):55-61. PubMed ID: 10488761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of dual recombinant vaccinia virus vectors to assay viral glycoprotein-mediated fusion with transfection-resistant primary cell targets.
    Yi Y; Singh A; Cutilli J; Collman RG
    Methods Mol Biol; 2004; 269():333-46. PubMed ID: 15114024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.
    Lin G; Murphy SL; Gaulton GN; Hoxie JA
    J Virol Methods; 2005 Sep; 128(1-2):135-42. PubMed ID: 15941597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SP6 RNA polymerase containing vaccinia virus for rapid expression of cloned genes in tissue culture.
    Usdin TB; Brownstein MJ; Moss B; Isaacs SN
    Biotechniques; 1993 Feb; 14(2):222-4. PubMed ID: 8431286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia virus-bacteriophage T7 expression vector for complementation analysis of late gene processes.
    Eckert D; Merchlinsky M
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1463-1469. PubMed ID: 10374964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages.
    Broder CC; Berger EA
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):9004-8. PubMed ID: 7568061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of recombinant gene expression in stably transfected cell lines using attenuated vaccinia virus MVA expressing T7 RNA polymerase with a nuclear localisation signal.
    Huemer HP; Strobl B; Shida H; Czerny CP
    J Virol Methods; 2000 Mar; 85(1-2):1-10. PubMed ID: 10716333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
    Nussbaum O; Broder CC; Berger EA
    J Virol; 1994 Sep; 68(9):5411-22. PubMed ID: 8057423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression using the vaccinia virus/ T7 RNA polymerase hybrid system.
    Elroy-Stein O; Moss B
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.15. PubMed ID: 18429181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient and inducible expression of vaccinia/T7 recombinant viruses.
    Mohamed MR; Niles EG
    Methods Mol Biol; 2004; 269():41-50. PubMed ID: 15114006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors.
    Broder CC; Kennedy PE; Michaels F; Berger EA
    Gene; 1994 May; 142(2):167-74. PubMed ID: 8194748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression using the vaccinia virus/T7 RNA polymerase hybrid system.
    Elroy-Stein O; Moss B
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.19. PubMed ID: 18265126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
    Wyatt LS; Moss B; Rozenblatt S
    Virology; 1995 Jun; 210(1):202-5. PubMed ID: 7793072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
    Fuerst TR; Niles EG; Studier FW; Moss B
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8122-6. PubMed ID: 3095828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.
    Volchkov VE; Becker S; Volchkova VA; Ternovoj VA; Kotov AN; Netesov SV; Klenk HD
    Virology; 1995 Dec; 214(2):421-30. PubMed ID: 8553543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
    Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
    Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
    Sutter G; Ohlmann M; Erfle V
    FEBS Lett; 1995 Aug; 371(1):9-12. PubMed ID: 7664891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viable double vaccinia virus recombinants with the non-inducible phage T7 expression system.
    Kriajevska MV; Zakharova LG; Altstein AD
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():47-53. PubMed ID: 8423450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.
    Lefkowitz EJ; Pattnaik AK; Ball LA
    Virology; 1990 Oct; 178(2):373-83. PubMed ID: 2171187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plasmid that improves the efficiency of foreign gene expression by intracellular T7 RNA polymerase.
    Takahashi T; Ryan KW; Portner A
    Genet Anal Tech Appl; 1992 Jun; 9(3):91-5. PubMed ID: 1476796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.